These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18846510)

  • 21. High-content analysis of CCR2 antagonists on human primary monocytes.
    Kredel S; Wolff M; Hobbie S; Bieler M; Gierschik P; Heilker R
    J Biomol Screen; 2011 Aug; 16(7):683-93. PubMed ID: 21540351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphoproteomic characterization of the signaling network resulting from activation of the chemokine receptor CCR2.
    Huang C; Foster SR; Shah AD; Kleifeld O; Canals M; Schittenhelm RB; Stone MJ
    J Biol Chem; 2020 May; 295(19):6518-6531. PubMed ID: 32241914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemokines in vascular dysfunction and remodeling.
    Schober A
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1950-9. PubMed ID: 18818421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of MCP-1/CCR2 signaling does not inhibit intimal proliferation in a mouse aortic transplant model.
    Alexis JD; Pyo RT; Chereshnev I; Katz J; Rollins BJ; Charo IF; Taubman MB
    J Vasc Res; 2008; 45(6):538-46. PubMed ID: 18463419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of CC chemokine receptor 2 on microglia activation and blood-borne cell recruitment after transient focal cerebral ischemia in mice.
    Schilling M; Strecker JK; Ringelstein EB; Schäbitz WR; Kiefer R
    Brain Res; 2009 Sep; 1289():79-84. PubMed ID: 19559679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists.
    Cherney RJ; Brogan JB; Mo R; Lo YC; Yang G; Miller PB; Scherle PA; Molino BF; Carter PH; Decicco CP
    Bioorg Med Chem Lett; 2009 Feb; 19(3):597-601. PubMed ID: 19131247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights into CC Chemokine Ligand 2/Chemokine Receptor 2 Molecular Recognition: A Step Forward toward Antichemotactic Agents.
    David KS; Oliveira ERA; Horta BAC; Valente AP; de Paula VS
    Biochemistry; 2017 Jun; 56(25):3197-3210. PubMed ID: 28570817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The molecular structure and role of CCL2 (MCP-1) and C-C chemokine receptor CCR2 in skeletal biology and diseases.
    Zhu S; Liu M; Bennett S; Wang Z; Pfleger KDG; Xu J
    J Cell Physiol; 2021 Oct; 236(10):7211-7222. PubMed ID: 33782965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases.
    Bose S; Cho J
    Arch Pharm Res; 2013 Sep; 36(9):1039-50. PubMed ID: 23771498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Turn-over of meningeal and perivascular macrophages in the brain of MCP-1-, CCR-2- or double knockout mice.
    Schilling M; Strecker JK; Ringelstein EB; Kiefer R; Schäbitz WR
    Exp Neurol; 2009 Oct; 219(2):583-5. PubMed ID: 19615366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [CCL2 chemokine and transmission of nociceptive information].
    Mélik-Parsadaniantz S
    Biol Aujourdhui; 2010; 204(4):301-9. PubMed ID: 21215247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments.
    Kang YS; Cha JJ; Hyun YY; Cha DR
    Expert Opin Investig Drugs; 2011 Jun; 20(6):745-56. PubMed ID: 21466412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Capped diaminopropionamide-glycine dipeptides are inhibitors of CC chemokine receptor 2 (CCR2).
    Carter PH; Brown GD; Friedrich SR; Cherney RJ; Tebben AJ; Lo YC; Yang G; Jezak H; Solomon KA; Scherle PA; Decicco CP
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5455-61. PubMed ID: 17720492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elucidation of binding sites of dual antagonists in the human chemokine receptors CCR2 and CCR5.
    Hall SE; Mao A; Nicolaidou V; Finelli M; Wise EL; Nedjai B; Kanjanapangka J; Harirchian P; Chen D; Selchau V; Ribeiro S; Schyler S; Pease JE; Horuk R; Vaidehi N
    Mol Pharmacol; 2009 Jun; 75(6):1325-36. PubMed ID: 19297521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1/CCR2.
    Tominaga T; Miyazaki D; Sasaki S; Mihara S; Komatsu N; Yakura K; Inoue Y
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5181-8. PubMed ID: 19553621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of disubstituted cyclohexanes as a new class of CC chemokine receptor 2 antagonists.
    Cherney RJ; Mo R; Meyer DT; Nelson DJ; Lo YC; Yang G; Scherle PA; Mandlekar S; Wasserman ZR; Jezak H; Solomon KA; Tebben AJ; Carter PH; Decicco CP
    J Med Chem; 2008 Feb; 51(4):721-4. PubMed ID: 18232650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monocyte chemoattractant protein-1 (MCP-1) produced via NF-kappaB signaling pathway mediates migration of amoeboid microglia in the periventricular white matter in hypoxic neonatal rats.
    Deng YY; Lu J; Ling EA; Kaur C
    Glia; 2009 Apr; 57(6):604-21. PubMed ID: 18942743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel sulfone-containing di- and trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists.
    Cherney RJ; Mo R; Meyer DT; Voss ME; Lo YC; Yang G; Miller PB; Scherle PA; Tebben AJ; Carter PH; Decicco CP
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3418-22. PubMed ID: 19481449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a binding element for the cytoplasmic regulator FROUNT in the membrane-proximal C-terminal region of chemokine receptors CCR2 and CCR5.
    Toda E; Terashima Y; Esaki K; Yoshinaga S; Sugihara M; Kofuku Y; Shimada I; Suwa M; Kanegasaki S; Terasawa H; Matsushima K
    Biochem J; 2014 Jan; 457(2):313-22. PubMed ID: 24128342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of 3-aminopyrrolidine derivatives as CC chemokine receptor 2 antagonists.
    Lim JW; Oh Y; Kim JH; Oak MH; Na Y; Lee JO; Lee SW; Cho H; Park WK; Choi G; Kang J
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2099-102. PubMed ID: 20223662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.